The Science – Anpac Bio

Advancing early cancer screening and detection.

Anpac Bio’s Cancer Differentiation Analysis can detect multiple cancers with high sensitivity and specificity.

Anpac Bio uses proprietary algorithms to measure and analyze these signals at multiple biological levels.

Analyzing blood samples with CDA technology.

26 Cancer types detected

Detects the risks of 26 different types of cancer—often identifying cancer at its early stages: Covering 80% of cancer incidences in China from 2013 to 2018

128 Patents granted

128 issued patents granted to date around its Cancer Differentiation Analysis (“CDA”) technology.

Cost Savings

Significant cost advantages compared to other screening technologies

Market Potential

In addition to cancer screening and risk detection, Anpac Bio’s CDA technology has demonstrated potential to assist physicians in cancer diagnosis, prognosis and recurrence.

How CDA Technology Works

Results speak. Take a look at our research.

Read the research Anpac Bio scientists presented at the American Society of Clinical Oncology, the San Antonio Breast Cancer Symposium, and the Nobel Prize Laureate Summit on Biomedical Sciences.

Read the Abstracts

Matching innovative engineering with clinical research.

We work with clinicians and scientists to improve our understanding of the biophysics of cancer across the world in the emerging liquid biopsy field.

“game changing”

Read about our CDA technology at the Nobel Prize Laureate Summit on Biomedical Science (NPLS) publications.

Read the full article

Quick Links

Contact Information

Anpac Technology USA (Anpac Bio)
3 Spring House Innovation Park, Suite 150
Ambler, PA 19002

Email: [email protected]

Phone Number: +1 (267) 810-6776

Anpac Bio-Medical Science Co., Ltd.

Anpac Bio is a biotechnology company focusing on early cancer screening and detection and marketing a suite of cancer detection tests, including CDA (Cancer differentiation analysis), bio-chemistry, immunology, and genomics tests. Anpac has developed a multi-cancer screening and detection test that uses innovative, patented Cancer Differentiation Analysis (CDA) technology and proprietary cancer-detection device.